Difference between revisions of "LINC01138"

From LncRNAWiki
Jump to: navigation, search
Line 10: Line 10:
 
===RefSeq(supplied by NCBI)===
 
===RefSeq(supplied by NCBI)===
 
NR_027468
 
NR_027468
===pubmed IDs===
+
LINC01138
27556357
 
 
===Disease===
 
===Disease===
 
prostate cancer
 
prostate cancer

Revision as of 14:24, 13 November 2017

Annotated Information

Approved Symbol

LINC01138C (long intergenic non-protein coding RNA 1138)

Previous Symbols

LINC00875

Synonyms

FLJ39739

Chromosome

1q21.2

RefSeq(supplied by NCBI)

NR_027468 LINC01138

Disease

prostate cancer

Expression

The expression level of LINC01138 is markedly increased in invasive extraprostatic tumors (pT3a, pT3b and T4 stages) as compared with intraprostatic localized tumors (pT2a , pT2b and pT2c stages).[1]

Function

The high level of LINC01138 is correlated with a short biochemical recurrence-free survival times.[1] LINC01138 promotes the proliferation and inhibited apoptosis of PCa.[1] LINC01138 functions as an oncogenes in prostate cancer.[1]

Labs working on this lncRNA

  • State Key Laboratory of Genetic Engineering, Shanghai Engineering Research Center Of Industrial Microorganisms, School of Life Science, Fudan University, Shanghai 200433, PR China.

References

  1. 1.0 1.1 1.2 1.3 Wan, X., et al., Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Oncotarget, 2016. 7(37): p. 60503-60518.